Prelude Capital Management, LLC Daxor Corp Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$12.83 - $15.83 $98,611 - $121,669	-7,686 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.6 - $14.25 $5,082 - $8,421	591 Added 8.33%	7,686 $104,000
Q4 2019 Feb 14, 2020	SELL	$8.94 - $9.93 $17,191 - $19,095	-1,923 Reduced 21.32%	7,095 $67,000
Q3 2019 Nov 14, 2019	SELL	$7.81 - $9.87 $94,930 - $119,969	-12,155 Reduced 57.41%	9,018 $87,000
Q2 2019 Aug 14, 2019	BUY	$7.5 - $11.61 $15,555 - $24,079	2,074 Added 10.86%	21,173 $168,000
Q1 2019 May 15, 2019	BUY	$9.11 - $19.52 $172,561 - $369,747	18,942 Added 12064.97%	19,099 $215,000
Q4 2018 Feb 14, 2019	BUY	$4.7 - $9.55 $737 - $1,499	157 New	157 $1,000

87.3K

Ticker DXR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 4,041,670
Market Cap $33.2M
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.